Anis A. Khan - Concepedia

Author

Anis A. Khan

Also Known As

A A Khan, A Khan, A. A. Khan, A. Khan, A.A. Khan, AMIR ZEB KHAN, Aamir Inayat Khan, Anis A Khan, Anis A. Khan, Anis Ahmed Khan

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Palo Alto Institute Stanford University AstraZeneca (United States)Medical Research Foundation Westmead Institute

About

Anis A. Khan is an author at Palo Alto Institute specializing in medicine, immunology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	827
2	Health Sciences	2	2	66
3	Allergy	2	2	363
4	Natural Sciences	1	1	67
5	Public Health	1	1	33

Anis A. Khan

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants M. Pamela Griffin, Yuan Yuan, Therese Takas, New England Journal of Medicine	2020	699
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants Qing Zhu, Jason S. McLellan, Nicole L. Kallewaard, Science Translational Medicine Rsv FusionRespiratory Virus ImmunityImmunologyImmunodominanceRsv Prophylaxis	2017	339
Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants Joseph B. Domachowske, Anis A. Khan, Mark T. Esser, The Pediatric Infectious Disease Journal	2018	222
Breast Cancer Resistance Protein (Bcrp/abcg2) Is a Major Determinant of Sulfasalazine Absorption and Elimination in the Mouse Hani Zaher, Anis A. Khan, Joe Palandra, Molecular Pharmaceutics	2006	159
Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults M. Pamela Griffin, Anis A. Khan, Mark T. Esser, Antimicrobial Agents and Chemotherapy	2016	143
In Vivo Activities of Farnesyl Pyrophosphate Synthase Inhibitors against <i>Leishmania donovani</i> and <i>Toxoplasma gondii</i> Vanessa Yardley, Anis A. Khan, Michael Martin, Antimicrobial Agents and Chemotherapy	2002	127
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors Johanna C. Bendell, Patricia LoRusso, Michael J. Overman, Cancer Immunology Immunotherapy	2023	90
Effect of Trovafloxacin on Production of Cytokines by Human Monocytes Anis A. Khan, Teri R. Slifer, Jack S. Remington Antimicrobial Agents and Chemotherapy	1998	72
Protection against Lipopolysaccharide-Induced Death by Fluoroquinolones Anis A. Khan, Teri R. Slifer, Fausto G. Araujo, Antimicrobial Agents and Chemotherapy ImmunotoxicologyImmunologyCell DeathPharmacotherapyAntimicrobial Chemotherapy	2000	72
Antimalarial, Antiviral, and Antitoxoplasmosis Norsesterterpene Peroxide Acids from the Red Sea Sponge <i>Diacarnus erythraeanus</i> Khalid A. El Sayed, Mark T. Hamann, Nadia E. Hashish, Journal of Natural Products Antiparasitic AgentMalariaImmunologyAntiviral DrugPlasmodium Falciparum	2001	67

Page 1